Theophylline
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-026 -
Package NDC
62332-026-30 -
Package NDC
62332-026-31 -
Package NDC
62332-026-71 -
Application number
ANDA090430 -
SPL ID
d9cbb2b7-6524-4587-9111-e3abfd2e888b -
SPL set ID
77e849b8-900b-4f0d-ac5c-1391abcd5721 -
UNII
0I55128JYK -
RxCUI
314241 -
RxCUI
317769
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- Theophylline
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Theophylline",
"splId": "d9cbb2b7-6524-4587-9111-e3abfd2e888b",
"labels": [
{
"setId": "77e849b8-900b-4f0d-ac5c-1391abcd5721",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77e849b8-900b-4f0d-ac5c-1391abcd5721",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=77e849b8-900b-4f0d-ac5c-1391abcd5721"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-30)",
"package_ndc": "62332-026-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20160129"
},
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-31)",
"package_ndc": "62332-026-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20160129"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-71)",
"package_ndc": "62332-026-71",
"identifierStatus": "well-formed",
"marketing_start_date": "20160129"
}
],
"productId": "62332-026_d9cbb2b7-6524-4587-9111-e3abfd2e888b",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "62332-026",
"deaSchedule": null,
"genericName": "Theophylline",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "THEOPHYLLINE ANHYDROUS",
"strength": "450 mg/1"
}
],
"applicationNumber": "ANDA090430",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160129",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175790",
"M0023046"
],
"unii": [
"0I55128JYK"
],
"rxcui": [
"314241",
"317769"
],
"spl_set_id": [
"77e849b8-900b-4f0d-ac5c-1391abcd5721"
],
"pharm_class_cs": [
"Xanthines [CS]"
],
"pharm_class_epc": [
"Methylxanthine [EPC]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-026_d9cbb2b7-6524-4587-9111-e3abfd2e888b"